483 AstraZeneca Pharmaceuticals LP Jun 2018

483 AstraZeneca Pharmaceuticals LP Jun 2018

Gene Arcy FDA, Jacqueline Diaz Albert FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 20 Jun 2018.

Product details

  • Category: Biologics
  • Inspection end: 20 Jun 2018
  • Location: Philadelphia, United States
  • FEI: 3004829714
Add To Cart